of pregnancies despite apparent ovarian failure have appeared. Though some apparently occurred without any therapy (Alper Although the transfer of fertilized donor oocytes is the et al., 1986; Shanis and Check, 1992) , most cases involved most efficacious mode of conception for infertile women women who were on some form of oestrogen replacement with hypergonadotrophism associated with incipient or (Polansky and DePapp, 1976; Shangold et al., 1977 ; Shapiro apparent ovarian failure, there are many individuals who, and Rubin, 1977; Szlachter et al., 1979; Ohsaiva et al., 1985 ; for religious, ethical, or personal reasons, would prefer to Check et al., 1989a Check et al., , 1990c . Some ovulations and pregnancies try to conceive with their own oocytes. The three cases followed human menopausal gonadotrophin (HMG) therapy presented here represent extremes to date for (i) highest (Johnson and Peterson, 1979; Tanaka et al., 1982 ; Fleming serum FSH concentration in a woman with incipient et al., 1984; Check, 1990a) . Some women failed to ovulate ovarian failure (n ⍧ 2), and (ii) the oldest woman with with HMG alone, but were successful when oestrogen and apparent overt ovarian failure (n ⍧ 1) to have successful HMG were combined (Check and Chase, 1984 ; Check et al., pregnancies. All three cases were treated for only a short 1989b, 1990c, 1991) .
time with pharmacological dosages of ethinyl oestradiol
When counselling patients it is sometimes of benefit to with luteal phase support with progesterone. The peak know extreme limits. Women seeking help with infertility FSH (mIU/ml) in cases 1 and 2 was 143 and 127 respectively. might be more willing to try a particular avenue of treatment, The precedents set in these cases can help physician-patient even if the odds of success are quite low, as long as a precedent consultation when patients enquire whether there is a exists. The purpose of this manuscript is to describe three cases certain critical FSH concentration above which pregnancy that may represent the women with the highest documented is not possible or an age over which successful pregnancy concentrations of serum FSH (cases 1 and 2) and the oldest could not be achieved even if ovulation despite ovarianIntroduction It has been known for decades that elevated early follicular A 36 year old gravida 1, para 1 presented with a 3 year history of infertility. She still had menses but they varied from a 1 to phase follicle stimulating hormone (FSH) concentrations predict a paucity of follicles (Goldenberg et al., 1973 ; Lenton 4 month interval. On initial presentation, while the serum oestradiol was Ͻ20 pg/ml (Diagnostic Products Corp RIA, et al., 1988) . There have been data presented that suggest that once the serum FSH is elevated, the oocytes released each Los Angeles, CA, USA), the serum FSH was 143 mIU/ml (Bayer Immunol. EIA, Tarrytown, NY, USA). Her last menmonth are most likely to be defective (Muasher et al., 1988; Fenichel et al., 1989; Scott et al., 1989; Tanbo et al., 1989;  strual cycle had started 47 days prior to the initial visit. Subsequently her FSH was recorded at 101.4 mIU/ml while Ahmed Ebbiary et al., 1994) . Donor oocyte programmes are frequently recommended. However, there are data suggesting the luteinizing hormone (LH) was 54.3 mIU/ml and the serum oestradiol 29 pg/ml. A magnetic resonance imaging (MRI) that euoestrogenic women 39 years old or younger with elevated serum FSH concentrations can achieve approximately scan failed to find evidence of a pituitary tumour. She was placed on 20 µg ethinyl oestradiol and she responded by a 45% 6 month pregnancy rate following therapy aimed at correcting follicular maturation abnormalities and luteal phase achieving a mature follicle on her first cycle of therapy. Ethinyl oestradiol was used rather than other oestrogens because it The serum FSH gradually decreased to a concentration of 17 mIU/ml by day 18 with the serum oestradiol reaching does not cause a rise in serum 17β oestradiol). She conceived on her second cycle with a dominant follicle of 18 mm average 212 pg/ml, and on ultrasound a follicle with an average diameter of 18.3 mm was found. She was given 10 000 units diameter and serum oestradiol of 294 pg/ml; her FSH decreased to 6 mIU/ml. She successfully delivered vaginally at full term.
of HCG and an intrauterine insemination (IUI) was performed 40 h later. She was given extra progesterone supplementation She had also been supplemented with progesterone vaginal suppositories in the luteal phase which was increased to 400 mg 100 mg ϫ2/day of vaginal suppositories but she failed to conceive. During the luteal phase, the ethinyl oestradiol was with the diagnosis of pregnancy plus the addition of oral micronized progesterone 100 mg ϫ4/day. stopped and 4 mg oral oestradiol was given. She failed to conceive and the progesterone and oral oestradiol were stopped Case 2 and 0.02 mg of ethinyl oestradiol was given once again. On day 11 she attained a serum oestradiol of 236 pg/ml with a A 35 year old woman presented with primary infertility and oligomenorrhoea with intervals between menses of more than serum FSH of 11 pg/ml and had one dominant follicle measuring 19.2 mm. Following IUI, progesterone vaginal 2 months but less than 3 months. She was diagnosed previously at another reproductive endocrine practice with incipient suppositories were again administered and she conceived during that cycle. She delivered a full-term healthy baby. ovarian failure based on an early follicular phase serum FSH of 22 mIU/ml while the serum oestradiol was Ͻ20 pg/ml. By history she was positive for anti-ovarian antibodies. She Discussion had also failed to achieve a rise in her serum oestradiol above 50 pg/ml despite two cycles of clomiphene citrate (50 mg Certainly, the large majority of patients presenting with findings similar to cases 1, 2 and 3 would be unsuccessful in achieving ϫ5 days and 100 mg ϫ5 days) and two cycles of HMG therapy.
On her initial presentation, 36 days from her last menses, pregnancies. Thus, in general, the most appropriate recommendation for these individuals would be to consider using her FSH was 105 mIU/ml and LH was 89 mIU/ml. Menses were induced with medroxyprogesterone acetate (MPA) 10 mg donor oocytes. However, there are some couples who, for religious, financial, or for personal reasons, either would never and ethinyl oestradiol 0.02 mg. Her day 3 serum FSH was 69 mIU/ml while the serum oestradiol was 56 pg/ml. After consider the donor oocyte programme, or would only do so if they are sure they have exhausted any chance of conception 4 days of continued ethinyl oestradiol therapy (0.02 mg), the serum oestradiol increased to 671 pg/ml with an 18.3 mm with their own gametes. The three cases described here represent, we believe, in dominant follicle. After follicle collapse she was treated with progesterone vaginal suppositories 100 mg twice daily plus cases 1 and 2, women successfully conceiving with the highest serum FSH concentrations recorded to date, and in case 3 the oral oestradiol 2 mg. She failed to conceive. Her day 3 FSH for her next cycle was 127 mIU/ml and the serum oestradiol oldest woman with apparent overt menopause to ovulate and have a normal pregnancy. The importance of reporting these was 45 pg/ml. She was treated with 0.04 mg ethinyl oestradiol and by day 14 the serum oestradiol increased to 185 pg/ml cases is that if a patient with hypergonadotrophism requests fertility help and desires pregnancy with their own gametes, and the FSH was down to 16 mIU/ml. She was given 75 IU of HMG for 2 days and the follicle increased to a 13.6 mm they should not be denied such treatment because of the belief that their high concentration of serum FSH precludes any diameter and the serum oestradiol was 254 pg/ml. She was increased to 225 IU HMG for 1 day and given 10 000 units chance of successful conception, or that their age (at least up to 45 years) makes pregnancy with their own gametes impossible. human chorionic gonadotrophin (HCG) the following evening (she was unable to return for blood or ultrasound tests on the Instead they should be advised that although conception is highly unlikely, and that donor oocytes would be far more day of HCG injection). The oocyte was released by day 19 and she was supplemented with progesterone vaginal efficacious, nevertheless, at least two natural pregnancies were recorded with serum FSH concentrations Ͼ100 mIU/ml and suppositories 100 mg twice daily and oral oestradiol 2 mg. She conceived in this cycle and had a successful full-term delivery.
another with very advanced age and apparent overt ovarian failure.
Case 3
The authors have a second reason for wanting to present these cases besides the establishment of upper limits for A 45 year old woman with primary infertility of 5 years duration sought help. Her last menstrual period was 6 months concentration of serum FSH and age with elevated FSH for the achievement of successful pregnancies. There are no previously. She had a serum FSH concentration drawn 3 months prior to her initial visit and it was 35 mIU/ml. Two attempts controlled studies that determine the mechanism for ovulation despite elevated FSH and oestrogen deficiency. Though most to induce menses with MPA 10 mg for 13 days failed to induce menses. Her serum oestradiol upon presentation was ovulations have occurred with women on oestrogen therapy, it is not clear if the ovulation could have occurred fortuitously 15 pg/ml and her serum FSH was 43 mIU/ml. Her husband's semen analysis was considerably subnormal at a concentration independent of oestrogen. However, the possibility exists that oestrogen treatment may of 3.3ϫ10 6 /ml with only 20% motility. They were not interested in IVF with intracytoplasmic sperm injection.
increase the likelihood of ovulation despite hypergonadotropic hypogonadism. One hypothesis is that it may improve the She was placed on ethinyl oestradiol 0.02 mg per day and she was monitored by serial serum FSH and oestradiol.
sensitivity of the FSH receptor. Another hypothesis is that the Pregnancies despite high FSH and advanced age woman's chronic FSH elevation leads to down-regulation of The relatively quick success of these patients with very inexpensive therapy allows the treating physician at least to the FSH receptors in the few remaining follicles, leading to the inability to respond to either endogenous or exogenous advise a couple not interested in using donor oocytes or adoption that, although a successful outcome is unlikely, there FSH. However, by lowering the serum FSH, the FSH receptors are restored and the follicles can now once again respond to does not appear to be a ceiling on the FSH concentration where conception in a woman with incipient ovarian failure gonadotrophins.
The distinction between the two hypotheses of how oestrogen is not possible. Furthermore, they can be advised that there is at least one precedent for temporary reversal of apparent overt therapy may help to facilitate ovulation despite hypergonadotrophism is clinically important because if actual lowering of menopause with successful delivery in women up to the age of 45 years. the elevated FSH concentrations is critical, then better results would be likely to occur if a pharmacological dosage of oestrogen is used rather than a physiological replacement References dosage. There are some anecdotal published reports that support too consistent (especially with 19% achieving pregnancies) to Obstet. Gynecol., 162, [775] [776] be explained by mere spontaneous ovulation, as is sometimes Check, J.H. and Adelson, H.G. (1990b) Case report: opposite responses to the addition of leuprolide acetate to human menopausal gonadotropin seen in women on oestrogen replacement (Check et al., 1990c oocyte maturation by using exogenous gonadotrophins, and
Lenton, E.A., Sexton, L., Lee, S. et al. (1988) (and it is not clear that the gonadotrophin boost was essential).
